We determined the role of miR-148a in breast cancer angiogenesis after transfecting anti-miR-148a into breast cancer cells and found that the decreased expression or secretion of VEGF was reversed, indicating that miR-148a had a negative effect on angiogenesis. The gene discussed is VEGFA; the disease is breast cancer.